Epstein Files Search

EFTA01547035Set 10

2013-06-30124p12,917w

09/25/13 (ID: 780097-71-3) 9/25 9/25 Free Delivery Free Delivery SANGAMO BIOSCIENCES INC ASSET TRANSFER TO A/C W92099-0 SOUTHERN FINANCIAL, LLC AS OF 09/25/13 ... Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG SANGAMO BIOSCIENCES INC Total US Small/Mid Cap Equity 800677-10-6 SGMO ... 09/25/13 (ID: 780097-71-3) 9/25 9/25 Receipt of Assets Receipt of Assets SANGAMO BIOSCIENCES INC ASSET TRANSFER FROM A/C W91850-0 SOUTHERN FINANCIAL, LLC AS OF 09/25/13

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01547035.pdf

EFTA01193595Set 9

2014-03-267p1,645w

pricing. EFTA01193595 Description Trade Date Quantity Last Prices Unit Cost Market Value Unrealized G/L SANGAMO BIOSCIENCES 05/28/2013 50,000.00 $ 19.80 $ 8.44 $ 990,000.00 $ 567,786.00 BIOGEN 02/14/2012 ... Volume 29340 k Jun Dec • Mar 2013 2014 Sangamo - 1 yr Price History ISGMO US Market 1(19.85/21.400 2 2 • Prey 19.80 Vol 2,907, 036 li 99 Save

https://www.justice.gov/epstein/files/DataSet%209/EFTA01193595.pdf

EFTA01972427Set 10

2013-05-283p431w

Dubov, Anastasia X Subject: RE: Well received. Will buy 50,000 of SGMO (Sangamo Biosciences). Spend around $413K. Paul Paul Barrett I Managing Director I Global Investment Opportunities Group ... Barrett, Paul Subject: please buy 50k shares of sangamo EFTA_R1_00455820 EFTA01972428 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01972427.pdf

EFTA00807456Set 9

2015-06-1013p4,518w

GROUP IN 50.500 (3.407) -3.61% -70% 1.074.468 $94,435 11/30/2017 21.28 1.87 -$980.033 928/13 SANGAMO THERAPEUTICS 40,000 (28,582) -6.14% 282% 337,771 $465,548 11/9/2017 ... GROUP INC 20.000 N 20.Oct-17 $ 425,532 $40.000 21.28 2.00 $385,532 5/28/13 SANGAMO THERAPEUTICS INC 10.000 N 23.Oct-17 $ 84,443 5139.006 8.44 13.90 $54.563 Total Southern Financial

https://www.justice.gov/epstein/files/DataSet%209/EFTA00807456.pdf

EFTA01410573Set 10

2014-06-0558p7,430w

Dividend Option: Cash 04/01/15 HEALTH NET INC COM Dividend Option: Cash 09/08/14 25,000.000 SANGAMO BIOSCIENCES INC COM Dividend Option: Cash 80097137CSF30023 ... Period: 06/01/2015 - 06/30/2015 Portfolio Holdings (continued) Date Acquired Quantity Equities (continued) Common Stocks (continued) SANGAMO BIOSCIENCES INC COM (continued) 05/28/13 *,13 50,000.000 SANTANDER CONSUMER USA HLDGS INC COM Dividend

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01410573.pdf

EFTA00961278Set 9

2013-05-282p467w

Dubov, Anastasia X Subject: RE: Well received. Will buy 50,000 of SGMO (Sangamo Biosciences). Spend around $413K. Paul Paul Barrett I Managing Director I Global Investment Opportunities Group ... Barrett, Paul S Subject: please buy 50k shares of sangamo The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended

https://www.justice.gov/epstein/files/DataSet%209/EFTA00961278.pdf

EFTA01038634Set 9

2018-06-083p545w

Paul Barrett < wrote: OK What about: Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney? Paul Barrett Alpha Group Capital LLC 142 W 57th Street, 11 th Floor ... will also sell BRKJA, GILD, SPOT and Chinese Life. Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney are legacy positions. Happy to clean those up. Your call

https://www.justice.gov/epstein/files/DataSet%209/EFTA01038634.pdf

EFTA01038754Set 9

2018-06-094p688w

Paul Barrett wrote: OK What about: Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney? Paul Barrett Alpha Group Capital LLC 142 W 57th Street. 11th Floor ... will also sell BRIUA, GILD, SPOT and Chinese Life. EFTA01038755 Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney are legacy positions. Happy to clean those up. Your

https://www.justice.gov/epstein/files/DataSet%209/EFTA01038754.pdf

EFTA01193516Set 9

2014-03-257p1,482w

pricing. Description Trade Date Quantity Last Price• Unit Cost Market Value Unrealized G/L SANGAMO BIOSCIENCES 05/2W2013 50,000.00 S 19.80 5 8.44 $ 990,000.00 $ 567,786.00 BIOGEN 02/14/2012 ... Volume 29340 • SM~~i81S)tji X4.756 14.75611 Jun Sep Dec Mar 2013 2014 Sangamo - lyr Price History SGMO US $ S Market ti K19.85 /21.40Q 2 x2 Prey

https://www.justice.gov/epstein/files/DataSet%209/EFTA01193516.pdf

EFTA01119309Set 9

2014-08-0120p8,368w

SANGAMO BIOSCIENCES INC COM Security Identifier: SGMO Dividend Option: Cash CUSIP: 800677106 Page 8 of 20 P.al eel O cellent 01••••• mese ItinkineLLO. . SW, end enagni/eir 110097252CSE30015 OBAS.ROO. Go paperless ... Basis Market Price Market Value Gain/Loss Annual Income Yield Equities (continued) Common Stocks (continued) SANGAMO BIOSCIENCES INC COM (continued) 05/28/13

https://www.justice.gov/epstein/files/DataSet%209/EFTA01119309.pdf

EFTA01193523Set 9

2014-03-258p1,571w

pricing. EFTA01193523 Description Trade Date Quantity Last Prices. Unit Cost Market Value Unrealized G/L SANGAMO BIOSCIENCES 05/28/2013 50,000.00 $ 19.80 $ 8.44 $ 990,000.00 $ 567,786.00 BIOGEN 02/14/2012 ... Volume 29340 kitimix415444.756M` 11 Jun Sep Lec Vol 2013 ?C14 Sangamo - 1yr Price History EFTA01193526 SGMO US K19.8.5 /21.40Q 2 2 19.80 )1 2 907.036 SGMO US ui 99 Save

https://www.justice.gov/epstein/files/DataSet%209/EFTA01193523.pdf

EFTA01038647Set 9

2018-06-094p576w

Paul Barrett < wrote: OK What about: Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney? Paul Barrett Alpha Group Capital LLC 142 W 57th Street, 11th Floor ... will also sell BRK/A, GILD, SPOT and Chinese Life. Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney are legacy positions. Happy to clean those up. Your call

https://www.justice.gov/epstein/files/DataSet%209/EFTA01038647.pdf

EFTA01038467Set 9

2018-06-084p542w

Paul Barrett > wrote: OK What about: Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney? Paul Barrett Alpha Group Capital LLC 142 W 57th Street, 11th Floor ... will also sell BRKIA, GILD, SPOT and Chinese Life. EFTA01038468 Biogen, Centene, Foundation Medicine, Sangamo, Allergan, Sequential Brands, BMY and Disney are legacy positions. Happy to clean those up. Your

https://www.justice.gov/epstein/files/DataSet%209/EFTA01038467.pdf

EFTA01466586Set 10

2014-01-1013p2,976w

SFLLC EQUITY 16535 6.76 17.5988 111776.59999999999 290997.4 -179220.80000000005 -0.6158845405491596 Multiple 6.76 0 0 Hold SANGAMO BIOSCIENCES INC COM SGMO SANGAMO BIOSCIENCES INC COM SFLLC EQUITY

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01466586.pdf

EFTA01470592Set 10

2014-08-0156p7,453w

Security Identifier: JPM CUSIP: 46625H100 4,353.000 SANGAMO BIOSCIENCES INC COM Dividend Option: Cash B0097252CSF30015 488.4840 2,126,372.76 59.4500 Security Identifier: SGMO CUSIP: 800677106 Page 8 of 20 Account ... Portfolio Holdings (continued) U.S. DOLLARS (continued) Date Acquired Quantity Equities (continued) Common Stocks (continued) SANGAMO BIOSCIENCES INC COM (continued) 05/28/13 *,13 50,000.000 SANTANDER CONSUMER USA HLDGS INC COM Dividend

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01470592.pdf

EFTA01971695Set 10

2013-05-282p169w

Subject: RE: Well received. Will buy 50,000 of SGMO (Sangamo Biosciences). Spend around $413K. Paul Paul Barrett I Managing Director I Global Investment Opportunities Group 13.P. Morgan Private ... Barrett, Paul S Subject: please buy 50k shares of sangamo The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01971695.pdf

EFTA01190526Set 9

2014-08-0120p8,442w

07/14/05 4.353.000 488.4840 2,126,372.76 59.4500 258.785.85 -1,867,586.91 6,964.80 2.69% SANGAMO BIOSCIENCES INC COM Security Identifier: SGMO Dividend Option: Cash CUSIP: 800677106 Page ... Basis 1bricet Price Market Value Gain/Loss Annual Income Yield Equities (continued) Common Stocks (continued) SANGAMO BIOSCIENCES INC COM (continued) 05/28/13 •,I3 50.000.000 8.4440 422,214.00 14.3000 715800.00 292.786.00 SANTANDER CONSUMER

https://www.justice.gov/epstein/files/DataSet%209/EFTA01190526.pdf

EFTA01157460Set 9

2014-05-084p1,087w

Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 12.17 $ 8.44 $ 608,500.00 422,214.00 186,286.00 smut 2/14/2012 ... Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 S 17.51 $ 8.44 $ 875,500.00 422,214.00 $ 453,286.00 BIOGEN 2/14/2012

https://www.justice.gov/epstein/files/DataSet%209/EFTA01157460.pdf

EFTA01455465Set 10

2004-06-011p905w

800.OOCORPORATE BOND USD 1,540,800.000CASH Long 107.0000 SGMO 800677106 SANGAMO BIOSCIENCES INC COM 50,000 648,500.OOCOMMON STOCK USD 648,500.000CASH Long 12.970009/10/2014

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01455465.pdf

EFTA01444780Set 10

2016-06-204p2,547w

SOUTHERN FINANCIAL LLC DBAB - Brokerage Account DB Securitie s Inc. Equity Small Cap 800677106 SANGAMO BIOSCIENCES INC COM N/A N/A 5000 O 422214 286000 0 286000 5.72 06/20/2016 N4G023804 SOUTHERN

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01444780.pdf